Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Interest Paid (2025 - 2026)

Updated

Adaptin Bio's Interest Paid came in at $4,696 for Q2 2026, up 141.7% from the prior quarter.

Analysis

Adaptin Bio (APTN) Interest Paid (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Adaptin Bio reported Interest Paid of $6,639; for FY2025, it came in at $9,584.

  • The Q2 2026 figure represents the highest quarterly Interest Paid since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 283.00 Mn
10 Adaptin Bio 56.76 Mn 54.75 Mn - 4,696.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4,696.00
Mar 31, 2026 1,943.00
Mar 31, 2025 9,584.00
API Access

Adaptin Bio Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=APTN&period=max&api_key=YOUR_API_KEY